Uncovering Age-Specific Invasive and DCIS Breast Cancer Rules Using Inductive Logic Programming Houssam Nassif, David Page, Mehmet Ayvaci, Jude Shavlik,

Slides:



Advertisements
Similar presentations
Mammary ductal carcinoma
Advertisements

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Carcinoma of the Prostate By: Ishan Parikh. Background on Cancer  Oldest information dates back to 3000 BC, Egyptian textbook on trauma surgery – “There.
COMPUTATIONAL INTELLIGENCE FOR THE DETECTION AND CLASSIFICATION OF MALIGNANT LESIONS IN SCREENING MAMMOGRAPHY DATA E. Panourgias,
In The Nam of God.
© Jesse Davis 2006 View Learning Extended: Learning New Tables Jesse Davis 1, Elizabeth Burnside 1, David Page 1, Vítor Santos Costa 2 1 University of.
What is cancer? A cancer is a malignant tumor, which are cells that multiply out of control, destroying healthy tissues (Dictionary)
Role of MRI in Breast Cancer Angela Kong Princess Margaret Hospital.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Breast Neoplasm In this section we will be discussing breast neoplasm.
The Facts about Breast Cancer
Breast Imaging Made Brief and Simple
Faculty of Medicine - Benha University
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Background on: Breast Cancer, X-Ray and MRI Mammography
Breast Cancer Screening Beyond 70 Years Old Henry Kwok Breast Imaging Fellow BreastScreen Aotearoa Counties Manukau.
Ductal Carcinoma in situ
Bayesian Network for Predicting Invasive and In-situ Breast Cancer using Mammographic Findings Jagpreet Chhatwal1 O. Alagoz1, E.S. Burnside1, H. Nassif1,
Integrated Cancer Screening Education Modules.  A disease that starts in the cells  Genes inside cells order growth, work, reproduction and death What.
Marion C.W. Henry, MD Yale University
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Breast Cancer Awareness Marissa Gregg. What is Breast Cancer?  Breast Cancer forms in the breast  It is a tumor in the breast  Breast cancer is the.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Russell A. Patterson Affiliation: Uniformed Services University.
 General recommendations -adjuvant systemic therapy :with tamoxifen or multiple-chemotherapy agent :lower the incidence of recurrence by about 30% - in.
Age Stratified Risk Prediction of Invasive versus In-situ Breast Cancer: A Logistic Regression Model Mehmet Ayvaci 1,2 Oguzhan Alagoz 1,Jagpreet Chhatwal.
Imaging examinations of breasts
Introduction to Breast Imaging BREAST RAD LAB Directions: Please answer all the questions prior to interactive conference. 1.
Integrating Machine Learning and Physician Knowledge to Improve the Accuracy of Breast Biopsy Inês Dutra University of Porto, CRACS & INESC-Porto LA Houssam.
Extracting BI-RADS Features from Portuguese Clinical Texts H. Nassif, F. Cunha, I.C. Moreira, R. Cruz- Correia, E. Sousa, D. Page, E. Burnside, and I.
Improvement in Screening Radiologists’ Performance in an Organized Screening Program Nancy A. T. Wadden, MD, FRCPC Gregory Doyle, BSc, MBA Breast Screening.
Breast Complaints You gotta know when to screen em, know when to street em, know when to reassure, know when to refer.
Ostoesarcoma By: Tori Hagel. Osteosarcoma  A malignant tumor of bone in which there is a proliferation of osteoblast.  A type of bone cancer.
Introduction to Clinical Radiology: The Breast
How will you approach the 35-year old, with a 2x2x2cm, firm, mobile, well-circumscribed non-tender mass on her R breast?
Breast Lump Bilateral Breast Exam No Palpable MassPalpable Mass Age < 35Age > 35 Diagnostic Mammogram -- unless negative mammogram within the past 6 months.
AIM Statement The use of reminders to eligible patients in the Resident Clinic to have a mammogram will improve rates of screening. Over a 6 month period,
Breast Cancer in the Women’s Health Initiative Trial of Estrogen Plus Progestin For the WHI Investigators Rowan T Chlebowski, MD., Ph.D.
During this presentation the learner will be able to: 1. Understand current breast cancer screening guidelines for mammography. 2. Compare and contrast.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Vol 1. Cancer in general Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.
Information Extraction for Clinical Data Mining: A Mammography Case Study H. Nassif, R. Woods, E. Burnside, M. Ayvaci, J. Shavlik and D. Page University.
Breast Cancer »Breast cancer is a malignant tumor that starts in the cells of the breast. »The disease occurs almost entirely in women,but men can get.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
Date of download: 5/31/2016 From: Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years: A Comparative Modeling.
By: Anthony, Sophia, Jessica, Terrance, and Sierra.
Dr. Julia Flukinger Breast Radiologist, Director Breast MRI, Advanced Radiology May 21, 2106.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
The Elliott Breast Center * Baton Rouge, LA *
Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.
What is Breast Cancer ? Abnormal cells develop from normal cells in the breast to form tumors Abnormal cells develop from normal cells in the breast to.
SCORE AS YOU LIFT (SAYL) A Statistical Relational Learning Approach to Uplift Modeling Houssam Nassif 1, Finn Kuusisto 1, Elizabeth S. Burnside 1, David.
TMIST A Breast Cancer Screening Trial
Cancer Screening Guidelines
Ultrasound breast core needle biopsy
Mammograms and Breast Exams: When to start /stop mammograms
Contrast-enhanced Dedicated Breast CT: Initial Clinical Experience
Example 6: (A,B) Diagnostic mammography was obtained in this 70-year-old woman for a palpable mass in the right breast. There is a large speculated, irregular.
Ductal Carcinoma (Breast Cancer)
BREAST CANCER AWARENESS
But how to treat those with positive SLNB? Results and Discussion
The benefits and harms of breast cancer screening
Breast Cancer By:Nina Bullock.
Current Status of Breast Ultrasound
Automatic Extraction of BI-RADS Features from Cross-Institution and Cross-Language Free-Text Mammography Reports Houssam Nassif, Terrie Kitchner, Filipe.
Breast Cancer.
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.
Marion C.W. Henry, MD Yale University
Presentation transcript:

Uncovering Age-Specific Invasive and DCIS Breast Cancer Rules Using Inductive Logic Programming Houssam Nassif, David Page, Mehmet Ayvaci, Jude Shavlik, Elizabeth S. Burnside

The American Cancer Society, Cancer Facts & Figures 2009.

Mammogram Radiologist Routine screening No Radiology Report Abnormal finding? Yes Biopsy Benign Malignant Cancer InvasiveIn Situ

Biopsy Biopsy: – Costly – Invasive – Potentially painful Models based on mammography report and personal data help identify pre-biopsy cancer stage.

Cancer Stages: In Situ Cancer cells localized Did not spread Basement Membrane Abnormal cells

Cancer Stages: Invasive Cancer cells break through basement membrane Invade surrounding tissue Basement Membrane Abnormal cells

Treatment In Situ: – Can develop into Invasive – Excellent prognosis, less intensive treatment  Treat it “Overdiagnosis” (unnecessary treatment) Time to spread may be long – Patient may die of other causes

Problem Constraints Identify patient subgroups that would benefit most from treatment Use biopsy alternatives (like follow-up) Help patients make informed decisions, personalized medicine

Task Formulation Given: – Radiology reports – No biopsy Do: – Identify patient subgroups – Specify Invasive/In Situ probabilities

Data Radiology Report - Personal/family history - BIRADS code - Palpable lump - Mass specs - Calcifications... Match mammograms to biopsies 1063 Invasive, 412 In Situ cases Biopsy - Date - Breast side - Cancer stage...

Acronyms BI-RADS code: Breast Imaging Reporting and Data System – A number (0-6) summarizing the radiologist opinion and findings concerning a mammogram. – In increasing probability of malignancy: 1<2<3<0<4<5<6 DCIS: Ductal Carcinoma In Situ – One [and only?] type of In Situ Breast Cancer

Age Matters Apply Logistic Regression – Different attributes predict cancer stages in different age groups Stratify data (~menopausal status): – Older cohort (age => 65) (post-) – Middle cohort (50 <= age < 65) (peri-) – Younger cohort (age < 50) (pre-)

Age-Specific Attributes Find accurate age-specific attributes Inductive Logic Programming (ILP) confers added benefits beyond Logistic Regression: – Human comprehensible rules – Specific data subsets

Inductive Logic Programming Machine learning approach White-box classifier Constructs if-then rules Allows user interaction using background knowledge Operates on relational datasets

Example Assign mammograms to biopsies Discard: Record 11 since benign Stages since target of prediction Non-relational learner extracts: – BIRADS(10,100,5) – BIRADS(12,100,4) RecordPatientDateBIRADS / / /20094 PatientDateStage 10009/2010Invasive 10003/2008Benign 20007/2009In Situ

Link patients records, e.g: – Old study (id, old id) – Old biopsy (id, old id, result) – Access old study/biopsy attributes Compare attributes, e.g: – Mass size decrease (id, old id) – This-side breast BIRADS code increase (id, old id) ILP Predicate Invention

Example Cont’d Link records: OldStudy(10,11) Access previous study predicates: – BIRADS(11,100,3) – OldBiopsy(10,11,Benign) Compare predicates: – BIRADSincrease(10,11,3) RecordPatientDateBIRADS / / /20094 PatientDateStage 10009/2010Invasive 10003/2008Benign 20007/2009In Situ

Methodology Older Cohort Reports ILP Classifier Invasive v/s In Situ Rules Younger Cohort Reports Differential Prediction Older-Specific Invasive/In Situ Rules

Differential Prediction Limit to Older and Younger: – Maximize age and attribute difference – Leave-out peri-menopausal Define Invasive rules in Older: – Good Invasive prediction on older Precision > 60%, Recall > 10% – And significantly worse prediction on younger Precision difference p-value < 0.05

Invasive Rules in Older 1.The mammogram has a palpable lump in this- side breast. 2.The mammogram's indication for exam is “palpable lump”. 3.The mammogram's indication for exam is “palpable lump", and its other side BI-RADS < 3, and its mass margin is not reported.

Palpable Lump Higher occurrence in Younger Tendency in younger: – Rapid proliferation – Poor differentiation – In Situ thus more likely to be palpable Tendency in older: – Slow growth – When big enough to be palpable, almost certainly Invasive

Invasive Rules in Older Cont'd 1.The mammogram has an old-biopsy that was invasive 2.The mammogram has an old-biopsy that was invasive, and the biopsy happened within the same age group. Due to: – Longer life-span of older women – Higher recurrence of invasive tumors

In Situ Rules in Younger 1.The mammogram has a personal history of cancer in this-side breast, and this-side breast has a prior surgery, and its combined BI-RADS increased by at least 2 points compared to a previous study.

Recurrence A recurrence is a better predictor of In Situ in younger Contrast with previous rules, where invasive tumor recurrence is a better predictor of Invasive in older

Other Rules No rules met our criteria for: – In Situ in Older – Invasive in Younger Middle cohort behavior: – 2 rules like Older – 2 rules like Younger – 2 rules neither

Probabilities Rules Precision Older Precision Younger Recall Older Recall Younger Palpable 1 94%87%42%65% Palpable 2 95%86%35%62% Palpable 3 98%87%19%41% Invasive Biopsy 1 97%86%50%18% Invasive Biopsy 2 100%86%44%18% Younger Recurrence8%67%2%11%

Problem Solutions Identify patient subgroups that would benefit most from treatment => Rule coverage Use biopsy alternatives (like follow-up) => Pre-biopsy mammography report Help patients make informed decisions, personalized medicine => Assigning probabilities

Conclusion First differential predictive rules extraction method and application Personalized age-specific prediction New insight on: – Palpable lump – Recurrence